Stocks With The Highest
Upside Forecast
Based on 25,000+ 1-year price targets provided by
5,000+ Wall Street analysts over the past 3-months
Mega Cap
Over $200B
Large Cap
$10B to $200B
Mid Cap
$2B to $10B
Small Cap
$250M to $2B
Micro Cap
Under $250M
Communication Services
Consumer Discretionary
Consumer Staples
Energy
Financials
Healthcare
Industrials
Materials
Real Estate
Technology
Utilities
Communication Services
Advertising Agencies
Broadcasting
Electronic Gaming & Multimedia
Entertainment
Internet Content & Information
Publishing
Telecom Services
Consumer Discretionary
Apparel Manufacturing
Apparel Retail
Auto Manufacturers
Auto Parts
Auto & Truck Dealerships
Department Stores
Footwear & Accessories
Furnishings, Fixtures & Appliances
Gambling
Home Improvement Retail
Internet Retail
Leisure
Lodging
Luxury Goods
Packaging & Containers
Personal Services
Recreational Vehicles
Residential Construction
Resorts & Casinos
Restaurants
Specialty Retail
Textile Manufacturing
Travel Services
Consumer Staples
Beverages - Brewers
Beverages - Non-Alcoholic
Beverages - Wineries & Distilleries
Confectioners
Discount Stores
Education & Training Services
Farm Products
Food Distribution
Grocery Stores
Household & Personal Products
Packaged Foods
Tobacco
Energy
Oil & Gas Drilling
Oil & Gas Equipment & Services
Oil & Gas Exploration & Production
Oil & Gas Integrated
Oil & Gas Midstream
Oil & Gas Refining & Marketing
Thermal Coal
Uranium
Financials
Asset Management
Banks - Diversified
Banks - Regional
Capital Markets
Credit Services
Diversified Insurance
Financial Conglomerates
Financial Data & Stock Exchanges
Insurance Brokers
Life Insurance
Mortgage Finance
Property & Casualty Insurance
Reinsurance
Shell Companies
Specialty - Insurance
Healthcare
Biotechnology
Diagnostics & Research
Drug Manufacturers - General
Drug Manufacturers - Specialty & Generic
Healthcare Plans
Health Information Services
Medical Care Facilities
Medical Devices
Medical Distribution
Medical Instruments & Supplies
Pharmaceutical Retailers
Industrials
Aerospace & Defense
Airlines
Airports & Air Services
Building Products & Equipment
Business Equipment & Supplies
Conglomerates
Consulting Services
Electrical Equipment & Parts
Engineering & Construction
Farm & Heavy Construction Machinery
Industrial Distribution
Infrastructure Operations
Integrated Freight & Logistics
Marine Shipping
Metal Fabrication
Pollution & Treatment Controls
Railroads
Rental & Leasing Services
Security & Protection Services
Specialty Business Services
Specialty Industrial Machinery
Staffing & Employment Services
Tools & Accessories
Trucking
Waste Management
Materials
Agricultural Inputs
Aluminum
Building Materials
Chemicals
Coking Coal
Copper
Gold
Lumber & Wood Production
Other Industrial Metals & Mining
Other Precious Metals & Mining
Paper & Paper Products
Silver
Specialty Chemicals
Steel
Real Estate
Diversified REIT
Healthcare Facilities REIT
Hotel & Motel REIT
Industrial REIT
Mortgage REIT
Office REIT
Real Estate Development
Real Estate Diversified
Real Estate Services
Residential REIT
Retail REIT
Specialty REIT
Technology
Communication Equipment
Computer Hardware
Consumer Electronics
Electronic Components
Electronics & Computer Distribution
Information Technology Services
Scientific & Technical Instruments
Semiconductor Equipment & Materials
Semiconductors
Software - Application
Software - Infrastructure
Solar
Utilities
Diversified Utilities
Electric Utilities
Gas Utilities
Independent Power Producers
Renewable Electricity
Water Utilities
# | Name | Upside % |
Analysts bullish % |
|
---|---|---|---|---|
1 |
1
Iovance Biotherapeutics
IOVA
$807M
|
707%
upside
3 price targets
|
0
|
|
2 |
2
Larimar Therapeutics
LRMR
$335M
|
443%
upside
3 price targets
|
0
|
|
3 |
3
Compass Therapeutics
CMPX
$483M
|
406%
upside
3 price targets
|
0
|
|
4 |
ATYR
4
aTyr Pharma
ATYR
$524M
|
377%
upside
3 price targets
|
0
|
|
5 |
CMPS
5
Compass Pathways
CMPS
$461M
|
360%
upside
3 price targets
|
0
|
|
6 |
6
Regenxbio
RGNX
$455M
|
292%
upside
4 price targets
|
0
|
|
7 |
7
Structure Therapeutics
GPCR
$1.1B
|
291%
upside
4 price targets
|
0
|
|
8 |
8
Perspective Therapeutics
CATX
$251M
|
287%
upside
3 price targets
|
0
|
|
9 |
9
Kura Oncology
KURA
$700M
|
271%
upside
3 price targets
|
0
|
|
10 |
ALMS
10
Alumis Inc. Common Stock
ALMS
$485M
|
266%
upside
5 price targets
|
0
|
|
11 |
11
Intellia Therapeutics
NTLA
$1.25B
|
245%
upside
6 price targets
|
0
|
|
12 |
CAN
12
Canaan Creative
CAN
$372M
|
236%
upside
3 price targets
|
0
|
|
13 |
13
Taysha Gene Therapies
TSHA
$772M
|
229%
upside
5 price targets
|
0
|
|
14 |
14
Cullinan Oncology
CGEM
$450M
|
227%
upside
3 price targets
|
0
|
|
15 |
15
Biohaven
BHVN
$1.64B
|
225%
upside
7 price targets
|
0
|
|
16 |
16
Trevi Therapeutics
TRVI
$878M
|
212%
upside
5 price targets
|
0
|
|
17 |
BCYC
17
Bicycle Therapeutics
BCYC
$491M
|
212%
upside
4 price targets
|
0
|
|
18 |
18
Senseonics Holdings
SENS
$375M
|
201%
upside
3 price targets
|
0
|
|
19 |
19
Vera Therapeutics
VERA
$1.42B
|
197%
upside
3 price targets
|
0
|
|
20 |
TECX
20
Tectonic Therapeutic, Inc. Common Stock
TECX
$478M
|
196%
upside
3 price targets
|
0
|
|
21 |
21
Nurix Therapeutics
NRIX
$719M
|
191%
upside
5 price targets
|
0
|
|
22 |
22
ATAI Life Sciences
ATAI
$997M
|
191%
upside
3 price targets
|
0
|
|
23 |
23
Semler Scientific
SMLR
$453M
|
188%
upside
3 price targets
|
0
|
|
24 |
24
Lexeo Therapeutics
LXEO
$257M
|
182%
upside
4 price targets
|
0
|
|
25 |
25
Edgewise Therapeutics
EWTX
$1.54B
|
181%
upside
3 price targets
|
0
|
|